Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

DRMA Dermata Therapeutics

Watchlist
0.330
+0.044+15.38%
Close  01/27 16:00 ET
0.330
+0.000+0.12%
Post Mkt Price 01/27 19:57 ET
High
0.352
Open
0.289
Turnover
288.74K
Low
0.289
Pre Close
0.286
Volume
898.02K
Market Cap
4.07M
P/E(TTM)
Loss
52wk High
2.450
Shares
12.32M
P/E(Static)
Loss
52wk Low
0.162
Float Cap
2.66M
Bid/Ask %
-90.00%
Historical High
6.950
Shs Float
8.06M
Volume Ratio
2.45
Historical Low
0.162
Dividend TTM
--
Div Yield TTM
--
P/B
0.54
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
11.14%
Amplitude
21.99%
Avg Price
0.321
Lot Size
1
Float Cap
2.66M
Bid/Ask %
-90.00%
Historical High
6.950
Shs Float
8.06M
Volume Ratio
2.45
Historical Low
0.162
Dividend TTM
--
P/B
0.54
Dividend LFY
--
Turnover Ratio
11.14%
Amplitude
21.99%
Avg Price
0.321
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
CEO: Mr. Gerald T. Proehl
Market: NASDAQ
Listing Date: 08/13/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist